ATE466587T1 - Valeriana officinalis extrakt zur behandlung von schlafapnoe oder hypopnoe - Google Patents

Valeriana officinalis extrakt zur behandlung von schlafapnoe oder hypopnoe

Info

Publication number
ATE466587T1
ATE466587T1 AT02748536T AT02748536T ATE466587T1 AT E466587 T1 ATE466587 T1 AT E466587T1 AT 02748536 T AT02748536 T AT 02748536T AT 02748536 T AT02748536 T AT 02748536T AT E466587 T1 ATE466587 T1 AT E466587T1
Authority
AT
Austria
Prior art keywords
hypopnea
treatment
sleep apnea
valeriana officinalis
officinalis extract
Prior art date
Application number
AT02748536T
Other languages
English (en)
Inventor
Axel Brattstroem
Original Assignee
Zeller Max Soehne Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zeller Max Soehne Ag filed Critical Zeller Max Soehne Ag
Application granted granted Critical
Publication of ATE466587T1 publication Critical patent/ATE466587T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/84—Valerianaceae (Valerian family), e.g. valerian
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/16—Central respiratory analeptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Anesthesiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT02748536T 2001-09-14 2002-08-16 Valeriana officinalis extrakt zur behandlung von schlafapnoe oder hypopnoe ATE466587T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US31886501P 2001-09-14 2001-09-14
PCT/CH2002/000448 WO2003024464A1 (en) 2001-09-14 2002-08-16 Pharmaceutical composition containing valerina officinalis extract

Publications (1)

Publication Number Publication Date
ATE466587T1 true ATE466587T1 (de) 2010-05-15

Family

ID=23239872

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02748536T ATE466587T1 (de) 2001-09-14 2002-08-16 Valeriana officinalis extrakt zur behandlung von schlafapnoe oder hypopnoe

Country Status (6)

Country Link
US (1) US20040241255A1 (de)
EP (1) EP1425026B1 (de)
JP (1) JP2005501923A (de)
AT (1) ATE466587T1 (de)
DE (1) DE60236299D1 (de)
WO (1) WO2003024464A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008046149A1 (en) * 2006-10-17 2008-04-24 Biologic Health Solutions Pty Ltd Herbal compositions for the prevention or treatment of restless leg syndrome
DE102011100832A1 (de) * 2011-05-07 2012-11-08 Dr. Loges + Co. Gmbh Wirkstoffkombinationen von Hesperidin zur Behandlung von Schlafstörungen
ES2694291T3 (es) * 2012-03-30 2018-12-19 Axel BRATTSTRÖM Nuevos extractos de valeriana y usos de los mismos
WO2020264324A1 (en) * 2019-06-26 2020-12-30 Kannalife Sciences, Inc. Use of certain phosphatidylcholines containing long chain polyunsaturated fatty acids as neuroprotective agents

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5629521A (en) * 1979-08-20 1981-03-24 Showa Denko Kk Prevention agent for snore
CH688791A5 (de) * 1995-05-12 1998-03-31 Zeller Max Soehne Ag Arzneimittelzubereitung.
CH690355A5 (de) * 1996-03-28 2000-08-15 Zeller Max Soehne Ag Verwendung von Extrakt aus Petasites hybridus sowie Verfahren und Vorrichtung zur Gewinnung des Extraktes.
US5869540A (en) * 1996-03-29 1999-02-09 Smith; Walter P. Herbal treatments for improving skin appearance
US6399116B1 (en) * 2000-04-28 2002-06-04 Rulin Xiu Rhodiola and used thereof

Also Published As

Publication number Publication date
EP1425026B1 (de) 2010-05-05
DE60236299D1 (de) 2010-06-17
EP1425026A1 (de) 2004-06-09
US20040241255A1 (en) 2004-12-02
JP2005501923A (ja) 2005-01-20
WO2003024464A1 (en) 2003-03-27

Similar Documents

Publication Publication Date Title
ATE449602T1 (de) Arzneimittel mit dobesilat-calcium zur behandlung und prophylaxe von sehnenerkrankungen
ATE291433T1 (de) Extrakte von mutterkraut (tanacetum parthenium) gegen entzündliche erkrankungen
SG146666A1 (en) Methods of using regenerative cells in the treatment of peripheral vascular disease and related disorders
ATE312635T1 (de) Ventilanordnung
ATE450269T1 (de) Peptid pyyä3-36ü zur behandlung von stoffwechselkrankheiten
ATE390142T1 (de) Synergistische zusammensetzung zur behandlung von diabetes mellitus
DE60109589D1 (de) Pharmazeutische zusammensetzung zur behandlung von akutem schmerz, chronischem schmerz und/oder neuropathischem schmerz und migräne
ATE332136T1 (de) Mittel, wie nikotinamide oder cadpr zur behandlung von hautkrankheiten
BR0214962A (pt) Composição para tratar distúrbios neurocerebrovasculares
ATE406897T1 (de) Kombination von et-743 mit 5-fluorouracil pro- drugs zur behandlung von krebs
ATE535237T1 (de) Verwendung von fts zur behandlung von malignen erkrankungen
DE69829202D1 (de) Verwendung von mirtazapine zur herstellung eines medikaments zur behandlung von schlafapnoen
RS50148B (sr) Upotreba docetaksela za lečenje hepatoćelijskog karcinoma
DE60143078D1 (de) Pax2 zur behandlung von nierenkrankheiten
WO2006022612A3 (en) Methods of using regenerative cells in the treatment of stroke and related diseases and disorders
DE60115054D1 (de) Pharmazeutische zusammensetzung die trkaig2 enthält zur verwendung in der vorbeugung und/oder behandlung von krebs
DE60236299D1 (de) Valeriana officinalis extrakt zur behandlung von schlafapnoe oder hypopnoe
DE60206280D1 (de) Verwendung von extrakten aus ginkgo biloba zur herstellung eines medikaments zur behandlung von sarcopenia
DE602006020838D1 (de) Medikamente zur prävention oder behandlung von herzversagen mit einem anticholinergikum
DE50100833D1 (de) Verwendung von 2-methyl-thiazolidin-2,4-dicarbonsäure und / oder ihrer physiologisch verträglichen salze zur herstellung eines medikaments zur behandlung von krebserkrankungen
ATE487480T1 (de) Perhexilin zur behandlung von chronischer herzinsuffizienz
ATE454896T1 (de) Heilkräuterzusammensetzung zur behandlung von aids
ATE345805T1 (de) Calciumtrifluoracetat mit zytotoxischer wirkung
ATE409042T1 (de) Verwendung von sulodexide zur behandlung von diabetischer nephropathie
TW200501973A (en) Method of improvement of blood circulation

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties